Biosyent Inc V.RX

Alternate Symbol(s): BIOYF

Healthcare

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.

TSXV:RX - Post by User

Biosyent Inc > Small Cap Discoveries

<< Previous

Bullboard Posts

Next >>

Comment by juanonaon Feb 01, 2024 11:34pm

202 Views

Post# 35858734

RE:Small Cap Discoveries

Excellent overview of Biosyent and management's approach to running the business. Rene has been a superb leader. It feels like critical mass is coming together for solid growth going forward. Thank you for sharing this interview. I've been a shareholder since 16 cents and plan to hold for years if not decades longer.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in